Evaluation of the ACT day clinic at Vivantes Klinikum Kaulsdorf

Phase 2

• Conditions: F00-F99; Mental and behavioural disorders

• Registration Number: DRKS00029992
• Lead Sponsor: Klinik für Psychiatrie, Psychotherapie und Psychosomatik Vivantes - Klinikum Kaulsdorf

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-11-14
• Study Start: 2022-08-19
• Results First Posted: 2023-01-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 171

Inclusion Criteria

written informed consent to participate in the study

Exclusion Criteria

- Filling in the questionnaires too late (more than two days after admission)
- Treatment duration of less than 38 days
- Admission to the clinic before the start of COVID restrictions (March 16, 2020).

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Symptom reduction: Beck Depression Inventory - Revision (BDI-II) and Symptom Checklist (SCL-90-S).<br>T1: admission day<br>T2: discharge<br>T3: 3-month follow-up

Secondary Outcome Measures

Name	Time	Method
Psychological flexibility: Acceptance and Action Questionnaire (AAQ II) (T1, T2, T3)<br><br>Quality of life: World Health Organization Quality of Life - Short Version (WHOQOL-BREF) (T1, T2, T3)<br><br>Global level of functioning: Global Assessment of Functioning Scale (GAF) (T1, T2)<br><br>Adverse effects: Inventory for the Assessment of Negative Effects after Psychotherapy (INEP) (T3)